Mediators of Inflammation / 2012 / Article / Tab 1

Clinical Study

Alterations in Monocyte CD16 in Association with Diabetes Complications

Table 1

Demographic and clinical parameters of control and diabetic subjects with or without complications.

( )( )D−Comps ( )D+Comps ( )

Age (yrs)
Duration (yrs)n.a.
Weight (kg)
BMI (kg/m2)
HbA1c (%)n.a.
Serum creatinine ( mol/L)#66.0 (62.3–80.0)80.0 (70.0–95.0)*70.0 (63.5–83.5)89.5 (79.8–103.8)
U Alb/Cr ratio (mg/mmol) #0.7 (0.6–1.2)1.5 (0.8–3.0)*0.9 (0.6–1.5)3.2 (1.9–8.9)
eGFR (mL/min)
Triglycerides (mmol/L)
HDL cholesterol (mmol/L)
LDL cholesterol (mmol/L)
Sys BP (mmHg)
Dias BP (mmHg)

Results are expressed as mean ± SD, except (#) shown as median with interquartile range (IQR).
Significantly different if indicated as (*) for controls versus diabetes and () for D−Comps versus D+Comps.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.